Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 14, 2012

View Archived Issues

NanoCarrier and LFB Biotechnologies refocus research collaboration

Anergis reports long-term immunomodulation with AllerT vaccine

STOP-ALF study of OCR-002 begins

Preliminary clinical results presented for FG-4592 in hemodialysis patients

sGPVI as a risk marker in inflammatory arthritis

Edison Pharmaceuticals commences phase IIb trial of EPI-743 in children with Leigh syndrome

Kyowa Hakko Kirin files new application for KW-2246 in Japan

Aeterna Zentaris' phase I/II study of AEZS-108 advances

Novel dual NADPH oxidase inhibitor shows excellent safety/pharmacokinetic profile

NDA for nonhormonal therapy for menopausal vasomotor symptoms accepted for review by FDA

Vaccibody receives grant to develop therapeutic cervical cancer vaccine

Foundation Medicine develops genomic profiling collaborations

Phase I results presented for the FMP-012 malaria vaccine

Roche launches Elecsys HE4 assay in U.S.

MRC reports results of heterologus prime vaccination study at the ASTMH meeting in Atlanta

Teknologian Tutkimuskeskus patents new pollen allergen polypeptides

Novel enhancers of SMN2 expression presented by AMRI and HHS

AstraZeneca presents novel PI3K inhibitors

Allon Therapeutics completes treatment in pivotal davunetide trial

Researchers divulge new SERMs for the treatment of breast cancer

Sunshine Biopharma begins IND-enabling studies for Adva-27a

Otsuka Pharmaceutical patents new antibacterial agents

Nuron Biotech completes enrollment in pivotal NU-100 trial

Novartis discloses novel prodrugs of SGLT1/2 inhibitors

Tiltan Pharma enrolls first U.S. patient in phase II TL-118 study

Joint effort between Eisai and Epizyme results in new EZH2 inhibitors

Colby and MannKind sign agreement to develop cancer immunotherapy products

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 5, 2026.
Janssen Pharmaceutica reports new TMEM175 activators
BioWorld Science
Janssen Pharmaceutica NV has identified new endosomal/lysosomal proton channel TMEM175 activators that are potentially useful for the treatment of Parkinson’s...
Cancer specter looming, Abtect effect in UC wallops Abivax
BioWorld
Although analysts liked the data – calling them “truly amazing” and “transformational” – Wall Street apparently had qualms about three cancer cases that turned up...
FB-7033 demonstrates efficacy in MASH management
BioWorld Science
17-β-Hydroxysteroid dehydrogenase 13 (HSD17B13) and lipid transferase CIDEB are known to contribute to metabolic dysfunction-associated steatohepatitis (MASH)...
Preclinical results support Actinium’s radioconjugate ATNM‑400 for NSCLC
BioWorld Science
At the recent meeting of the Society of Nuclear Medicine and Molecular Imaging, researchers from Actinium Pharmaceuticals Inc. presented preclinical efficacy data...